Vocab. DA_France - OHDSI/Vocabulary-v5.0 GitHub Wiki
This vocabulary represents medicinal products available on the French market. The vocabulary is licensed by the IQVIA.
Transformation
The procedures for transforming Concepts from the source to the OMOP Standard Vocabularies can be found on the OHDSI GitHub.
The names of source concepts are assigned based on the set of available attributes, directly extracted from the source data.
The concept_code values related to source concepts (eg. Devices or fully defined drugs) are inherited from the source data, while attributive concepts (eg. Ingredients or Brand names) are OMOP-generated in the majority of cases.
All Drug concepts are Non-Standard. The majority of the concepts are mapped to standard drugs in the RxNorm, RxNorm Extension, or CVX vocabularies. The Device portion of vocabulary is standard.
All concepts belong to either Drug or Device domains.
The DA_France concepts are either attributive (Ingredient, Brand Name, Dose Form, Unit) or source entries (Drug Product, Branded Drug, etc.)
Ingredient |
Brand Name |
Dose Form |
Unit |
Drug Product |
Branded Drug |
Branded Drug Comp |
Branded Drug Form |
Clinical Drug Comp |
Device |
Clinical Drug |
Clinical Drug Box |
Clinical Drug Form |
Quant Branded Drug |
Branded Drug Box |
Quant Clinical Drug |
Quant Clinical Box |
Supplement |
Concept Relationships
DA_France concepts with drug properties are mapped to Standard Concepts (originating from RxNorm, RxNorm Extension, or CVX vocabularies) through records in the CONCEPT_RELATIONSHIP table.
DA_France Concepts are mostly non-Standard Concepts and therefore do not participate in the hierarchy of the CONCEPT_ANCESTOR table.